Showing results (1001-1010 of 1,017) with videos related to
Sort By:
Pageof 102
Journal of Medicinal Chemistry|February 7, 2017
Identification of Novel Triazole-Based Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors Endowed with Antiproliferative and Antiinflammatory ActivityCristina Travelli, Silvio Aprile, Reza Rahimian, et al.Recenti Progressi in Medicina|May 5, 2006
[Peer review about gastro-esophageal reflux disease in primary care: epidemiology, diagnostic and therapeutic management]Giuseppe Belleri, Lorenzo Comini, G Pietro Ramponi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 13, 2013
Abagovomab as maintenance therapy in patients with epithelial ovarian cancer: a phase III trial of the AGO OVAR, COGI, GINECO, and GEICO--the MIMOSA studyPaul Sabbatini, Philipp Harter, Giovanni Scambia, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 7, 2020
Donor heart and lung procurement: A consensus statementHannah Copeland, J W Awori Hayanga, Arne Neyrinck, et al.Science Signaling|August 2, 2018
CDK12-mediated transcriptional regulation of noncanonical NF-κB components is essential for signalingKate L Henry, Debra Kellner, Bekim Bajrami, et al.Archives of Gerontology and Geriatrics|July 26, 2008
Posatirelin for the treatment of degenerative and vascular dementia: results of explanatory and pragmatic efficacy analysesG Gasbarrini, G Stefanini, G Addolorato, et al.Proceedings of the National Academy of Sciences of the United States of America|May 14, 2020
A massively parallel barcoded sequencing pipeline enables generation of the first ORFeome and interactome map for riceShayne D Wierbowski, Tommy V Vo, Pascal Falter-Braun, et al.Giornale Italiano Di Cardiologia (2006)|March 14, 2018
[Consensus document and recommendations for the prevention of cardiovascular disease in Italy - 2018]Massimo Volpe, Giuliano Tocci, Domenico Accettura, et al.Cancer Immunology, Immunotherapy : CII|February 3, 2026
Effectiveness of ICI-ICI versus ICI-TKI combinations in patients with IMDC intermediate- and poor-risk metastatic renal cell carcinoma: a sub-analysis of the MEET-URO 33 studyMichele Maffezzoli, Alessio Signori, Alessandro Acunzo, et al.Leukemia|May 31, 2019
Second cancer in Philadelphia negative myeloproliferative neoplasms (MPN-K). A nested case-control studyTiziano Barbui, Arianna Ghirardi, Arianna Masciulli, et al.Pageof 102